Depression Screening Market Business Growth Analysis with Top Players: Vertical Pharmaceuticals, LLC, ACADIA Pharmaceuticals Inc., Medtronic, Meiji Holdings Company, Ltd., Bristol-Myers Squibb Company Considering COVID-19 Impact
04 juin 2020 08h17 HE
|
Data Bridge Market Research
NEW YORK, June 04, 2020 (GLOBE NEWSWIRE) -- The latest Depression Screening Market study by Data Bridge Market Research offers an all-inclusive, in-depth analysis of the major strategies, corporate...
Quality improvement interventions improve efficacy of depression screening and follow-up
03 janv. 2019 13h00 HE
|
The Joint Commission
OAKBROOK TERRACE, Ill., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Depression is the leading cause of disability and often goes unaddressed, particularly for minorities, immigrants and refugees.1–[2] While...
assessURhealth, LLC joins Greenway Health online Marketplace for comprehensive health IT solutions
02 janv. 2018 19h47 HE
|
assessURhealth, LLC
Tampa, FL, Jan. 02, 2018 (GLOBE NEWSWIRE) -- assessURhealth, LLC, a leading provider of mental and behavioral health screening software, today announced it has joined the Greenway Health online...
UPDATE-- assessURhealth, LLC Partners with athenahealth’s ‘More Disruption Please’ Program to Enhance Access to Mental and Behavioral Health Screening Tools
12 déc. 2017 10h23 HE
|
assessURhealth, LLC
Tampa, FL, Dec. 12, 2017 (GLOBE NEWSWIRE) -- assessURhealth, LLC, a provider of mental and behavioral health screening software, today announced a partnership with athenahealth, Inc. through...
assessURhealth, LLC Partners with athenahealth’s ‘More Disruption Please’ Program to Enhance Access to Mental and Behavioral Health Screening Tools
12 déc. 2017 08h01 HE
|
assessURhealth, LLC
Tampa, FL, Dec. 12, 2017 (GLOBE NEWSWIRE) -- assessURhealth, LLC, a provider of mental and behavioral health screening software, today announced a partnership with athenahealth, Inc. through...